Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Peptide Mapping Companies and Competitive Landscape

Date : 07 July 2026

Top Vendors in the Peptide Mapping Market & Their Offerings

Peptide Mapping Market Companies are Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Danaher Corporation, Shimadzu Corporation, Bruker Corporation, Merck KGaA

Market Ecosystem Analysis

Ecosystem Segment Major Participants Role in the Market
Technology Providers Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, SCIEX, Bruker Develop LC-MS systems, UHPLC instruments, peptide analysis workflows, and analytical technologies.
Product Manufacturers Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bio-Rad Laboratories Manufacture chromatography systems, mass spectrometers, sample preparation kits, enzymes, and analytical consumables.
Service Providers SGS SA, Charles River Laboratories, Eurofins Scientific, Intertek Group, WuXi AppTec Provide peptide mapping, protein characterization, GMP analytical testing, and regulatory support services.
Platform Providers Thermo Fisher Scientific, Waters Corporation, SCIEX, Bruker Offer integrated analytical platforms combining LC, MS, software, and workflow automation.
CROs/CDMOs WuXi AppTec, Lonza, Charles River Laboratories, SGS SA, Eurofins Scientific Deliver analytical development, comparability studies, biosimilar characterization, and release testing.
Software Vendors Thermo Fisher Scientific (BioPharma Finder), Waters Corporation (UNIFI), SCIEX (SCIEX OS), Bruker (Compass), Agilent Technologies (MassHunter) Provide peptide identification, PTM analysis, sequence confirmation, spectral interpretation, and regulatory reporting software.
Research Institutions National Institute of Standards and Technology (NIST), Broad Institute, University of Cambridge, Johns Hopkins University, NIH laboratories Develop reference standards, analytical methodologies, and peptide characterization research.
End-User Industries Biopharmaceuticals, Biotechnology, Vaccines, Cell & Gene Therapy, Academic Research Utilize peptide mapping for protein characterization, regulatory compliance, and biologics quality assurance.

Supply Chain Analysis

R&D

  • Peptide mapping is a key analytical technique used in biopharmaceutical research and development to verify protein sequences and evaluate critical quality attributes, including post-translational modifications, oxidation, and deamidation. It plays an essential role in ensuring protein identity, quality, and consistency.
  • Key Players: Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, and Shimadzu Corporation.

Regulatory Approvals

  • Peptide mapping is an essential analytical method used to confirm the amino acid sequence, structural integrity, and quality of therapeutic proteins and peptides. It supports regulatory compliance by ensuring product identity, purity, and batch-to-batch consistency during drug development and approval.
  • Key Players: Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, and Shimadzu Corporation.

Competitive Landscape

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Peptide Mapping
Thermo Fisher Scientific Waltham, Massachusetts USA Industry leader in proteomics, LC-MS, and biopharma analytical workflows Orbitrap MS, Vanquish UHPLC, BioPharma Finder, peptide mapping workflows
Waters Corporation Milford, Massachusetts USA Leading supplier of LC-MS solutions for biologics characterization ACQUITY UPLC, Xevo MS, BioAccord, UNIFI Software
Agilent Technologies Santa Clara, California USA Comprehensive analytical instrumentation portfolio for protein characterization InfinityLab LC, Q-TOF LC/MS, MassHunter Software
SCIEX Framingham, Massachusetts USA Strong presence in biotherapeutic peptide mapping and high-resolution MS TripleTOF, ZenoTOF, SCIEX OS Software
Bruker Corporation Billerica, Massachusetts USA Major provider of high-resolution mass spectrometry for proteomics timsTOF, maXis II, Compass Software
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Peptide Mapping
Shimadzu Corporation Kyoto Japan Strong LC-MS portfolio for pharmaceutical analysis Nexera UHPLC, LCMS Series
Eurofins Scientific Luxembourg City Luxembourg Leading analytical CRO providing peptide mapping services Protein characterization, analytical testing
Charles River Laboratories Wilmington, Massachusetts USA Extensive biologics analytical characterization capabilities GMP peptide mapping, biosimilar characterization
SGS SA Geneva Switzerland Global analytical testing and biologics characterization provider Protein analytical services, peptide mapping
Lonza Group Basel Switzerland CDMO offering analytical development and biologics characterization Protein characterization and analytical development
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Peptide Mapping
WuXi AppTec Shanghai China Rapidly expanding biologics analytical testing services Protein characterization, peptide mapping services
Intertek Group plc London United Kingdom Specialized pharmaceutical analytical services Biologics characterization, peptide mapping
Bio-Rad Laboratories Hercules, California USA Supplies analytical reagents and protein analysis products Protein standards, analytical reagents
Creative Proteomics Shirley, New York USA Specialist proteomics service provider LC-MS peptide mapping, PTM analysis
Alphalyse A/S Odense Denmark Dedicated protein sequencing and peptide mapping specialist GMP peptide mapping, protein sequencing

What are the Recent Developments in the Peptide Mapping Market? 

  • In November 2025, Bruker Corporation introduced new machine learning capabilities in its ProteoScape software to enhance immunopeptidomics, post-translational modification (PTM) analysis, de novo peptide sequencing, and proteoform characterization, strengthening AI-powered peptide mapping and protein analysis workflows.
  • In June 2025, Isogenica partnered with Charles River Laboratories to advance next-generation peptide and VHH discovery by combining Isogenica’s peptide library platform with Charles River’s drug discovery and development capabilities, helping accelerate biologics research and development.

Market Growth

The peptide mapping market size marked US$ 1.28 billion in 2025 and is forecast to experience consistent growth, reaching US$ 1.41 billion in 2026 and US$ 3.27 billion by 2035 at a CAGR of 9.85%.

Peptide Mapping Market Size is USD 1.41 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales